| Dr Jennifer Fern Niesen, DO | |
|
1005 Bellefontaine Ave, Suite 175, Lima, OH 45804-2851 | |
| (419) 227-2727 | |
| (419) 227-2737 |
| Full Name | Dr Jennifer Fern Niesen |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 21 Years |
| Location | 1005 Bellefontaine Ave, Lima, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497806897 | NPI | - | NPPES |
| 2774387 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 9005 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lima Memorial Health System | Lima, OH | Hospital |
| Mercy Health-st Rita's Medical Center | Lima, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Womens Health For Life Inc | 5991738098 | 5 |
News Archive
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its patent application "Glycosylated IL-7, Preparation and Uses", US Patent Application Number 11/996,176. The Notice of Allowance is the USPTO's official communication that the Company's application has successfully completed examination and that a patent will be issued.
Research presented at the ASM Microbe research meeting provides compelling evidence that children acquire Streptococcus mutans, the bacterium most frequently associated with dental caries, from intra- and extra-familial sources besides their mother.
BioMarin Pharmaceutical Inc. today announced an update on the Phase I/II trial for BMN 110 or N-acetylgalactosamine 6-sulfatase (GALNS), intended for the treatment of the lysosomal storage disorder Mucopolysaccharidosis Type IVA (MPS IVA), or Morquio A Syndrome. Preliminary clinical data from the first 24 weeks of the study (12 weeks at 0.1mg/kg and 12 weeks at 1.0 mg/kg) have been evaluated, and BioMarin plans to announce top-line results for the full 36-week study after completion of dosing at 2.0 mg/kg in the second quarter of 2010.
A Miami Herald series "Neglected to Death," focused this spring on critical breakdowns in Florida's enforcement system, including failures by the state's Agency on Health Care Administration to fully investigate deaths or to shut down some of the worst offenders among Florida's 2,850 assisted-living facilities. Although more states are using Medicaid money to pay for some portion of assisted living care for the poor, the federal government has a limited role in the facilities their oversight has been and will likely continue to be a state duty.
› Verified 9 days ago
| Entity Name | Womens Health For Life Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285789362 PECOS PAC ID: 5991738098 Enrollment ID: O20050917000348 |
News Archive
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its patent application "Glycosylated IL-7, Preparation and Uses", US Patent Application Number 11/996,176. The Notice of Allowance is the USPTO's official communication that the Company's application has successfully completed examination and that a patent will be issued.
Research presented at the ASM Microbe research meeting provides compelling evidence that children acquire Streptococcus mutans, the bacterium most frequently associated with dental caries, from intra- and extra-familial sources besides their mother.
BioMarin Pharmaceutical Inc. today announced an update on the Phase I/II trial for BMN 110 or N-acetylgalactosamine 6-sulfatase (GALNS), intended for the treatment of the lysosomal storage disorder Mucopolysaccharidosis Type IVA (MPS IVA), or Morquio A Syndrome. Preliminary clinical data from the first 24 weeks of the study (12 weeks at 0.1mg/kg and 12 weeks at 1.0 mg/kg) have been evaluated, and BioMarin plans to announce top-line results for the full 36-week study after completion of dosing at 2.0 mg/kg in the second quarter of 2010.
A Miami Herald series "Neglected to Death," focused this spring on critical breakdowns in Florida's enforcement system, including failures by the state's Agency on Health Care Administration to fully investigate deaths or to shut down some of the worst offenders among Florida's 2,850 assisted-living facilities. Although more states are using Medicaid money to pay for some portion of assisted living care for the poor, the federal government has a limited role in the facilities their oversight has been and will likely continue to be a state duty.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jennifer Fern Niesen, DO 1005 Bellefontaine Ave, Suite 175, Lima, OH 45804-2851 Ph: (419) 227-2727 | Dr Jennifer Fern Niesen, DO 1005 Bellefontaine Ave, Suite 175, Lima, OH 45804-2851 Ph: (419) 227-2727 |
News Archive
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its patent application "Glycosylated IL-7, Preparation and Uses", US Patent Application Number 11/996,176. The Notice of Allowance is the USPTO's official communication that the Company's application has successfully completed examination and that a patent will be issued.
Research presented at the ASM Microbe research meeting provides compelling evidence that children acquire Streptococcus mutans, the bacterium most frequently associated with dental caries, from intra- and extra-familial sources besides their mother.
BioMarin Pharmaceutical Inc. today announced an update on the Phase I/II trial for BMN 110 or N-acetylgalactosamine 6-sulfatase (GALNS), intended for the treatment of the lysosomal storage disorder Mucopolysaccharidosis Type IVA (MPS IVA), or Morquio A Syndrome. Preliminary clinical data from the first 24 weeks of the study (12 weeks at 0.1mg/kg and 12 weeks at 1.0 mg/kg) have been evaluated, and BioMarin plans to announce top-line results for the full 36-week study after completion of dosing at 2.0 mg/kg in the second quarter of 2010.
A Miami Herald series "Neglected to Death," focused this spring on critical breakdowns in Florida's enforcement system, including failures by the state's Agency on Health Care Administration to fully investigate deaths or to shut down some of the worst offenders among Florida's 2,850 assisted-living facilities. Although more states are using Medicaid money to pay for some portion of assisted living care for the poor, the federal government has a limited role in the facilities their oversight has been and will likely continue to be a state duty.
› Verified 9 days ago
Marjorie Ann Demund, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1220 E Elm St Ste 101, Lima, OH 45804 Phone: 419-998-8245 Fax: 419-998-8247 | |
Dr. Maurice K Chung, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 310 S Cable Rd, Lima, OH 45805 Phone: 419-228-1000 Fax: 419-227-3085 | |
Dr. Scott C. Stallkamp, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 830 W High St, Ste 101, Lima, OH 45801 Phone: 419-227-0610 Fax: 419-228-3273 | |
Dr. Rhonda J Medina, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1220 E Elm St Ste 101, Lima, OH 45804 Phone: 419-998-8245 Fax: 419-998-8247 | |
Dr. Charles R Ryan, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 830 W High St, Ste 101, Lima, OH 45801 Phone: 419-227-0610 Fax: 419-228-3273 | |
Elizabeth Read Rumschlag, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 830 W High St Ste 101, Lima, OH 45801 Phone: 419-227-9354 Fax: 419-227-9354 | |
Darcy Langhals, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 830 W High St Ste 101, Lima, OH 45801 Phone: 419-227-0610 Fax: 419-228-3273 |